Methodologic Concerns in Secondary Analysis of KEYNOTE-048
JAMA Oncol
.
2022 Dec 1;8(12):1853-1854.
doi: 10.1001/jamaoncol.2022.5068.
Authors
Barbara Burtness
1
,
Jianxin Lin
2
,
Denis Souliéres
3
Affiliations
1
Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
2
Merck & Co Inc, Rahway, New Jersey.
3
Centre Hospitalier de l'Université de Montréal, Quebec, Montreal, Canada.
PMID:
36264563
DOI:
10.1001/jamaoncol.2022.5068
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment